Professor Kim Mi-hee of Hwasun Chonnam National University Hospital awarded 'Excellent Paper Award' by the Korean Association of Internal Medicine
Professor Kim Mi-hee of the Department of Hematology at Chosun Jeonnam National University Hospital was selected for the excellent paper award in the hematology-oncology field for the second half of 2023 by The Korean Journal of Internal Medicine, the official English journal of the Korean Association of Internal Medicine.
The Korean Association of Internal Medicine annually selects one outstanding paper per field from those published in its official SCIE-level international journal, The Korean Journal of Internal Medicine, during the first and second halves of the year and presents awards accordingly.
Professor Kim's paper is titled "The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine."
This study discovered the prognostic significance of reduced genetic burden in elderly patients with acute myeloid leukemia who received hypomethylation therapy.
In particular, the paper was honored for revealing that prognosis varies depending on the genetic mutations at diagnosis and the degree of reduction in genetic variant burden after the fourth treatment.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- SpaceX Pursues 'Largest Ever' Mega IPO... Profitability of Space Business Still Unclear
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Recognized as a promising researcher in various hematologic diseases and myeloid hematologic malignancies, Professor Kim stated, "This research can help predict early treatment response to hypomethylation therapy and assist in establishing the optimal treatment direction to improve patient prognosis."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.